[USE OF AURANTIN IN THE TREATMENT OF CHILDREN WITH LEUKEMIA AND LEUKEMIC RETICULOSES (LYMPHOGRANULOMATOSIS AND RETICULOLYMPHOSARCOMATOSIS). PRELIMINARY REPORT].
D000293:Adolescent; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002648:Child; D003609:Dactinomycin; D004358:Drug Therapy; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D008223:Lymphoma; D008228:Lymphoma, Non-Hodgkin; D020135:Peptide Nucleic Acids
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D020135:Peptide Nucleic Acids; D003609:Dactinomycin; C090194:aurantin
ADOLESCENCE; ANTIBIOTICS; ANTINEOPLASTIC AGENTS; CHILD; DRUG THERAPY; HODGKIN'S DISEASE; LEUKEMIA; LYMPHOSARCOMA
PRIMENENIE AURANTINA PRI LECHENII DETE I S LE IKOZOM I NELE IKEMICHESKIMI RETIKULOZAMI (LIMFOGRANULEMATOZOM I RETIKULOLIMFOSARKOMATOZOM). PREDVARITEL'NOE SOOBSHCHENIE.